Top Story

Angelina Jolie’s preventive mastectomy doubled one center’s referrals for genetic testing

September 2, 2014

Read the Perspective from Harold J. Burstein, MD, PhD

The number of genetic testing referrals nearly doubled at one center after Angelina Jolie publicly announced her decision to undergo preventive double mastectomy, according to results of a retrospective study presented at the Breast Cancer Symposium.

Although the proportions of referred women who subsequently qualified for genetic testing and were found to harbor BRCA1/2 mutations remained consistent, centers may face challenges as they try to meet the increasing demand for genetic services, researchers wrote.

Industry News

Enrollment starts in OPTIMA global study of ThermoDox as HCC therapy

September 2, 2014
The first patient enrolled in the OPTIMA study for primary liver cancer will be studied at the Kyungpook National University Hospital in South Korea, according to a news…
In the Journals

BRCA2 mutation associated with shorter survival in screen-detected prostate cancer

September 2, 2014
Men with screen-detected prostate cancer who harbor mutations in the BRCA2 gene demonstrated poorer-than-expected prognosis, according to study results.Prior research…
In the Journals

LT patients with cirrhosis had increased risk for colorectal neoplasia

September 2, 2014
Patients with viral or alcohol-related cirrhosis awaiting liver transplantation and who underwent colonoscopy were at high risk for developing colorectal neoplasia…
More News Headlines »
Cover Story

Thyroid cancer treatment no longer ‘one-size-fits-all’ approach

HemOnc Today, July 10, 2014
Thyroid cancer incidence is increasing faster than any other malignancy in the United States.
More »
Meeting News Coverage Video
figure

Docetaxel plus ADT improved OS in metastatic prostate cancer

June 24, 2014
CHICAGO — Donald L. Trump, MD, FACP, president and CEO at Roswell Park Cancer Institute and HemOnc Today
More »